Shares of Annovis Bio, Inc. (ANVS) have gained 0.9% over the past four weeks to close the last trading session at $11.88, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$35.40 indicates a potential upside of 198%. The mean estimate comprises five short-term price targets with a standard deviation of $22.13. While the lowest estimate of$13 indicates a 9.4% increase from the cur ...